查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1931285

經經皮視鏡胃造瘻裝置市場：依裝置類型、最終用戶、通路、材料、手術、年齡層分類，全球預測（2026-2032年）

Percutaneous Endoscopic Gastrostomy Device Market by Device Type, End User, Distribution Channel, Material, Procedure, Age Group - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，經皮胃造瘻裝置市場價值將達到 21.2 億美元，到 2026 年將成長至 22.4 億美元，到 2032 年將達到 33.2 億美元，年複合成長率為 6.58%。

關鍵市場統計數據
基準年 2025 21.2億美元
預計年份：2026年 22.4億美元
預測年份 2032 33.2億美元
複合年成長率 (%) 6.58%

對當代經皮胃造瘻裝置的發展趨勢進行權威分析，重點在於臨床優先事項、採購權衡和生命週期考量。

經皮視鏡胃造瘻裝置在臨床營養、長期照護和微創介入手術的交叉領域中發揮著至關重要的作用。這些裝置為經腸營養、藥物輸注和胃減壓提供了途徑，其設計、材質組成和輸送方式直接影響患者預後、看護者工作流程和醫療機構預算。近年來，隨著臨床趨勢的推進，例如提早出院、擴大居家照護以及加強對裝置相關併發症的防範，人們越來越關注裝置的易用性、耐用性和感染控制功能。

臨床實踐的改變、材料創新以及不斷演進的分銷模式如何重新定義經經皮胃造瘻通路裝置的產品設計重點和護理服務路徑

經經皮視鏡胃造瘻術 (PEG) 器材的市場格局正受到三大因素的共同影響：臨床實務、器材創新和醫療服務模式。微創技術和內視鏡視覺化技術的進步正在縮短手術時間並降低併發症率，從而催生了對快速置入和牢固固定器械的需求。同時，手術逐漸轉移到門診手術中心和居家醫療機構的趨勢，促使製造商和醫療服務提供者優先考慮使用者友善介面和低調的設計，以減輕看護者的培訓負擔並支持門診治療。

2025年美國關稅即將生效，這對胃造瘻機生態系統的供應鏈韌性、籌資策略和成本控制重點有何影響？

關稅的徵收和提高可能會對整個醫療設備供應鏈產生連鎖反應，而美國在2025年宣布的關稅措施則為製造商、經銷商和醫療器材採購商帶來了一個新的變數。關稅會增加進口零件和成品的到岸成本，促使製造商重新評估供應商選擇、定價策略和合約條款。為此，一些製造商可能會加快回流、近岸外包或雙重採購策略，以降低關稅波動帶來的風險。同時，其他製造商可能會尋求透過簡化設計或採用受關稅影響較小的替代材料來控制成本。

將醫療設備類型、臨床環境、通路、材料選擇、手術環境和患者人口統計特徵與臨床和商業性優先事項聯繫起來的綜合細分分析

細分市場分析表明，每種產品、臨床環境、通路、材料選擇、手術環境和患者群體都有其自身的動態變化，這些變化會影響臨床應用、採購決策和創新重點。依器械類型，器械可分為球囊固定式和非球囊固定式。球囊固定式器械可細分為Low profile球囊設計（優先考慮舒適性和門診適用性）和標準球囊設計（優先考慮已確立的臨床親和性）。同時，非球囊固定式解決方案可分為便於更換的外置緩衝裝置和優先考慮長期牢固固定的內置緩衝裝置。這些器械層面的差異會影響臨床醫生對初始植入和更換作業的偏好，並影響培訓和庫存管理政策。

區域戰略考量和差異化引進路徑，以符合美洲、歐洲、中東和非洲以及亞太地區的臨床需求、法規結構和分銷實踐。

區域趨勢塑造了採購重點、臨床通訊協定和競爭格局，並對產品策略產生重大影響。在美洲，成熟的醫院系統、不斷擴展的門診手術能力以及大規模的居家醫療行業共同推動了對兼具臨床可靠性和便捷性（適用於門診和家庭使用）的醫療器械的需求。支付者和醫療服務提供者也越來越關注能夠縮短住院時間和減少術後併發症的醫療程序。在歐洲、中東和非洲，監管的多樣性和醫療基礎設施的差異導致了不同的應用路徑。擁有先進醫療能力的都市區能夠迅速採用先進的醫療設備功能，而偏遠和資源匱乏的地區則優先考慮成本效益和供應鏈的可靠性。在亞太地區，不斷擴大的醫療服務覆蓋範圍、日益成長的手術量以及對門診和居家醫療基礎設施投資的增加，推動了對能夠在各種臨床環境中推廣應用的緊湊型、經濟高效型解決方案的需求。

從競爭和策略層面的企業觀點，闡述現有企業、利基創新者、契約製造製造商和分銷合作夥伴如何塑造產品領導地位和市場進入。

胃造瘻管市場的競爭格局呈現出多元化的特點，既有成熟的醫療設備製造商，也有專注於器材創新的廠商、契約製造製造商和專業經銷商。現有製造商憑藉其穩固的臨床關係和強大的服務能力，在醫院系統和綜合醫療網路中佔據優先供應商地位；而專注於創新的廠商則致力於在細分領域脫穎而出，例如低輪廓輸送系統、新型固定機制以及可減少生物污染的最佳化材料。契約製造和零件供應商的戰略重要性日益凸顯，他們不僅能夠加快原型製作和大量生產，還能起到緩衝作用，保護大型原始設備製造商免受供應鏈中斷的影響。

製造商和醫療保健服務合作夥伴應專注於以下實際策略事項，以協調和加速產品開發和分銷彈性以及臨床證據項目的採用。

產業領導者應採取多管齊下的方法，使產品設計與不斷發展的護理路徑保持一致，確保供應鏈的柔軟性，並加快證據產生以支持產品推廣應用。他們應優先考慮能夠縮短手術時間和減輕看護者負擔，同時保持植入可靠性的設備特性，並專注於低輪廓和模組化設計，以簡化初始植入和更換流程。此外，他們還應從患者舒適度和生命週期耐用性的角度評估材料選擇，並選擇能夠最大限度地減少更換頻率並降低機構採購者整體擁有成本的配方和製造流程。

我們不依賴定量市場預測，而是採用研究途徑，將臨床醫生對話、供應鏈分析和文獻綜合相結合，以檢驗可操作的研究結果。

本分析的研究結合了對領域專家、臨床醫生、採購主管和供應鏈專業人員的定性訪談，以及對同行評審的臨床文章、監管指導文件和行業技術文獻的嚴格審查。主要調查方法包括結構化訪談和針對性討論，旨在揭示實際決策標準、門診和家庭環境中的設備操作注意事項以及採購合約實務。次要研究整合了臨床結果研究、材料科學文獻和相關監管檢驗，以驗證設計影響和安全考慮因素。

結論：臨床創新、供應鏈韌性和實證商業化的結合將決定下一代胃造瘻裝置的成功。

總之，經皮視鏡胃造瘻裝置正從普通商品轉變為策略性臨床技術。其設計、材料選擇和分銷模式對臨床工作流程和患者體驗有顯著影響。球囊固定式和非球囊固定式裝置在裝置層面的差異、聚氨酯和矽膠之間微妙的材料權衡，以及初始置入和更換手術的不同要求，都為有針對性的創新指明了方向。醫療服務向門診手術中心和居家醫療機構的轉移，進一步推動了對輕鬆易用裝置和全面支持服務的需求，以減輕看護者的負擔，並確保患者在家中安全管理。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章經皮視鏡胃造瘻裝置市場（依裝置類型分類）

  • 球囊保留裝置
  • 非球囊固定裝置

第9章 經經皮胃造瘻裝置市場（依最終用戶分類）

  • 門診手術中心
  • 居家醫療環境
  • 醫院

第10章經皮視鏡胃造瘻裝置市場（依分銷管道分類）

  • 線上
  • 離線

第11章經皮胃造瘻裝置市場（依材料分類）

  • 聚氨酯裝置
  • 矽膠裝置

第12章經皮胃造瘻裝置市場（依手術類型分類）

  • 首次安裝
  • 更換程序

第13章 依年齡層別經皮視鏡胃造瘻裝置市場

  • 成年患者
  • 兒童患者

第14章經皮胃造瘻裝置市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章經皮胃造瘻裝置市場（依類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國經經皮視鏡胃造瘻裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國經皮視鏡胃造瘻裝置市場

第18章 中國經皮視鏡胃造瘻裝置市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Applied Medical Technology
  • Avanos Medical
  • Boston Scientific
  • Cardinal Health
  • ConMed
  • Cook Group
  • Danone
  • Fresenius Kabi
  • GBUK Group
  • Nestle
Product Code: MRR-7B550E008E09

The Percutaneous Endoscopic Gastrostomy Device Market was valued at USD 2.12 billion in 2025 and is projected to grow to USD 2.24 billion in 2026, with a CAGR of 6.58%, reaching USD 3.32 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.12 billion
Estimated Year [2026] USD 2.24 billion
Forecast Year [2032] USD 3.32 billion
CAGR (%) 6.58%

An authoritative orientation to modern percutaneous endoscopic gastrostomy device dynamics that clarifies clinical priorities, procurement trade-offs, and lifecycle considerations

Percutaneous endoscopic gastrostomy devices occupy a vital role at the intersection of clinical nutrition, long-term care, and minimally invasive access procedures. These devices are the conduit through which enteral nutrition, medication administration, and gastric decompression are performed, and as such their design, material composition, and delivery model have direct implications for patient outcomes, caregiver workflows, and institutional budgets. Over recent years, clinical practice has shifted toward earlier discharge, greater use of home-based care, and heightened sensitivity to device-related complications, driving greater scrutiny of device usability, durability, and infection control features.

Clinicians and procurement leaders now evaluate gastrostomy devices not merely on initial placement success but on lifecycle factors such as replacement frequency, ease of bedside exchange, patient comfort, and compatibility with ambulatory and home-care settings. Simultaneously, manufacturers have responded with differentiated designs that prioritize low-profile profiles, modular components, and simplified placement techniques. This evolution invites a reassessment of procurement criteria, clinical pathways, and partnership models across hospital systems, ambulatory surgery centers, and home healthcare providers. In short, the device category is maturing from a commoditized supply item to a strategic clinical asset that requires integrated consideration of clinical utility, supply chain resilience, and post-market support.

How clinical shifts, materials innovation, and evolving distribution models are collectively redefining product design priorities and care delivery pathways for gastrostomy access devices

The landscape for percutaneous endoscopic gastrostomy devices is being reshaped by converging forces in clinical practice, device innovation, and healthcare delivery models. Minimally invasive procedural techniques and enhanced endoscopic visualization are reducing procedural time and complication rates, which in turn is creating demand for devices optimized for rapid placement and secure retention. Concurrently, the migration of procedures toward ambulatory surgery centers and home healthcare settings is prompting manufacturers and providers to prioritize user-friendly interfaces and low-profile options that reduce caregiver training burdens and support outpatient pathways.

Materials science advances and a greater emphasis on infection prevention are establishing new baselines for device performance. Polyurethane and silicone formulations are being refined to balance flexibility, tensile strength, and biocompatibility, while incremental improvements in balloon retention and bumper designs are addressing leakage and tissue irritation concerns. On the commercial side, distribution models are shifting; direct sales relationships with large integrated health systems coexist with e-commerce and distributor channels that target smaller ambulatory and homecare purchasers. Taken together, these developments are moving the market toward modularity, differentiated clinical value propositions, and closer alignment between device features and care delivery settings.

Implications of impending United States tariff measures for 2025 on supply chain resilience, procurement strategies, and cost-containment priorities across the gastrostomy device ecosystem

The imposition and escalation of tariffs can have ripple effects across medical device supply chains, and the announced tariff measures in the United States for 2025 introduce a new variable for manufacturers, distributors, and healthcare purchasers. Tariffs increase landed costs for imported components and finished devices, prompting manufacturers to reassess supplier footprints, pricing strategies, and contract terms. In response, some manufacturers may accelerate reshoring, nearshoring, or dual-sourcing strategies to reduce exposure to tariff volatility, while others may pursue cost containment through design simplification or alternative materials that are less exposed to tariffed categories.

Healthcare providers and system purchasers will feel these effects through tighter procurement negotiations, potential repricing of consumables, and renewed emphasis on total cost of ownership when choosing between balloon retention and non-balloon retention devices or between polyurethane and silicone materials. Supply chain teams are therefore re-evaluating inventory policies, safety stock levels, and long-term supplier agreements to manage both cash flow and availability risk. Regulatory compliance and customs administration costs add another layer of operational complexity, requiring closer coordination among procurement, legal, and logistics functions. Ultimately, tariff-driven cost pressures may accelerate consolidation among suppliers and incentivize innovation that reduces per-procedure resource intensity, but they will also raise short-term procurement and budgeting challenges for healthcare buyers.

Integrated segmentation intelligence that maps device types, care settings, distribution pathways, material choices, procedural contexts, and patient demographics to clinical and commercial priorities

Segmentation insights reveal that product, care setting, distribution pathway, material selection, procedural context, and patient demography each present distinct dynamics that influence clinical adoption, procurement decisions, and innovation priorities. Based on device type, devices fall into balloon retention and non-balloon retention categories; balloon retention devices further differentiate into low-profile balloon designs that emphasize comfort and outpatient suitability and standard balloon devices that prioritize established clinical familiarity, while non-balloon retention solutions divide into external bumper devices that offer ease of replacement and internal bumper devices that emphasize secure long-term anchoring. These device-level distinctions inform clinician preference for initial placement versus replacement procedures and shape training and inventory policies.

Based on end user, the care environment shifts requirements: ambulatory surgery centers demand devices that facilitate quick turnover and same-day discharge protocols, home healthcare settings require devices with simplified maintenance and caregiver-friendly replacement options, and hospitals prioritize devices that integrate with complex case mixes and longer inpatient stays. Based on distribution channel, direct sales relationships support customized training and bundled service agreements with large systems, e-commerce platforms enable rapid replenishment for decentralized buyers, and medical distributors consolidate logistics for smaller purchasers. Based on material, polyurethane devices and silicone devices offer differentiated trade-offs in flexibility, patient comfort, and durability, affecting clinician selection and replacement cadence. Based on procedure, the distinct requirements of initial placement versus replacement procedures drive choices around device profile, insertion technique compatibility, and ancillary accessory availability. Based on age group, adult patients and pediatric patients present divergent anatomical and care considerations that influence device dimensioning, retention mechanism choice, and caregiver instruction sets. Integrating these segmentation layers yields a nuanced picture of where product innovation, targeted marketing, and supply chain optimization will generate the greatest clinical and commercial return.

Regional strategic considerations and differentiated adoption pathways that reconcile clinical needs, regulatory frameworks, and distribution realities across the Americas, Europe, Middle East & Africa, and Asia-Pacific

Regional dynamics shape procurement priorities, clinical protocols, and the competitive environment in ways that materially influence product strategy. In the Americas, a combination of mature hospital systems, growing ambulatory surgery capabilities, and a sizable home healthcare sector creates demand for devices that balance clinical robustness with ease of outpatient and home use, and payers and providers are increasingly focused on procedures that reduce length of stay and post-procedural complications. In Europe, Middle East & Africa, regulatory heterogeneity and varying levels of care infrastructure produce differentiated adoption pathways: high-acuity urban centers often adopt advanced device features rapidly, whereas remote or resource-constrained settings prioritize cost-effectiveness and supply chain reliability. In Asia-Pacific, expanding healthcare access, rising surgical volumes, and growing investment in ambulatory and home care infrastructure are driving demand for low-profile, cost-efficient solutions that can scale across diverse clinical environments.

These regional patterns influence everything from materials selection and device form factor to distribution strategies and post-market support models. For multinational manufacturers, successful regional playbooks blend centralized R&D and regulatory expertise with localized distribution partnerships, training programs, and value demonstration activities that match the operational realities of each geography. For regional suppliers and distributors, competitive differentiation often hinges on service quality, aftercare support, and the ability to tailor solutions to specific patient demographics and procedural norms.

Competitive and strategic company-level perspectives that describe how incumbents, niche innovators, contract manufacturers, and distribution partners shape product leadership and market access

The competitive landscape for gastrostomy devices is characterized by a mix of incumbent medical device manufacturers, specialized device innovators, contract manufacturers, and distribution-focused players. Incumbent manufacturers leverage established clinical relationships and broad service capabilities to secure preferred supplier status within hospital systems and integrated delivery networks, while specialized innovators focus on niche differentiation such as low-profile delivery systems, novel retention mechanisms, or materials optimized for reduced biofouling. Contract manufacturers and component suppliers play an increasingly strategic role, enabling faster prototyping and scale-up while also buffering large original equipment manufacturers against supply chain shocks.

Commercial success increasingly depends on integrated go-to-market strategies that combine clinician education, evidence generation through observational and real-world studies, and flexible distribution models tailored to ambulatory, hospital, and home healthcare channels. Partnerships that bundle training, remote monitoring, and consumable supply agreements create sticky relationships with care providers. Moreover, companies that invest in post-market surveillance and iterative product improvements demonstrate stronger clinician acceptance and lower rates of device-related complications. Financial discipline, strategic M&A to acquire complementary technologies, and investment in regulatory expertise to navigate multinational approval pathways are recurring themes among market leaders seeking to scale globally while maintaining localized support.

Actionable strategic priorities for manufacturers and provider partners to harmonize product development, distribution resilience, and clinical evidence programs for accelerated adoption

Industry leaders should pursue a multi-pronged agenda that aligns product design with care pathway evolution, secures supply chain flexibility, and accelerates evidence generation to support adoption. Prioritize device attributes that reduce procedural time and caregiver burden while maintaining retention reliability, focusing on low-profile and modular designs that simplify both initial placement and replacement procedures. Simultaneously, evaluate materials choices through the dual lenses of patient comfort and lifecycle durability, selecting formulations and manufacturing processes that minimize replacement frequency and reduce the total cost of ownership for institutional buyers.

On the commercial front, cultivate hybrid distribution models that combine direct relationships with integrated health systems and robust partnerships with e-commerce platforms and medical distributors to serve ambulatory and homecare clients. Strengthen supply chain resilience by diversifying supplier bases, considering nearshoring for critical components, and implementing longer-term purchasing agreements where appropriate to hedge against tariff-related volatility. Invest in targeted clinical evidence generation, including real-world data and comparative usability studies, to demonstrate value in ambulatory and homecare settings. Finally, develop comprehensive training and support packages for clinicians and caregivers, and align reimbursement and procurement teams early in product introduction to minimize barriers to adoption and ensure smooth integration into clinical pathways.

Research approach that integrates clinician engagements, supply chain analysis, and literature synthesis to validate practical insights without relying on quantitative market estimates

The research underlying this analysis combines primary qualitative engagement with domain experts, clinicians, procurement leaders, and supply chain specialists alongside a rigorous review of peer-reviewed clinical publications, regulatory guidance documents, and industry technical literature. Primary engagements included structured interviews and targeted discussions that illuminated real-world decision criteria, device handling considerations in ambulatory and home settings, and procurement contracting practices. Secondary research synthesized clinical outcome studies, materials science literature, and relevant regulatory filings to triangulate design implications and safety considerations.

Analytical steps included mapping device segmentation against care pathways and regional adoption patterns, assessing distribution channel economics, and evaluating material trade-offs with respect to clinical comfort and durability. Findings were validated through iterative consultations with practicing clinicians and supply chain professionals to ensure practical applicability. Throughout the research, emphasis was placed on synthesizing actionable insights rather than producing quantitative estimates, ensuring recommendations are grounded in observable trends, verified clinical considerations, and operational constraints that influence procurement and product development decisions.

Concluding perspective on the convergence of clinical innovation, supply chain resilience, and evidence-driven commercialization that will define next-generation gastrostomy device success

In conclusion, percutaneous endoscopic gastrostomy devices are transitioning from commodity items to strategic clinical technologies whose design, material selection, and distribution model materially affect clinical workflows and patient experience. Device-level distinctions between balloon retention and non-balloon retention technologies, nuanced material trade-offs between polyurethane and silicone, and the divergent requirements of initial placement versus replacement procedures create clear vectors for targeted innovation. The migration of care into ambulatory surgery centers and home healthcare settings amplifies the need for low-profile, user-friendly devices and comprehensive support offerings that reduce caregiver burden and enable safe home management.

At the same time, commercial realities such as tariff-related supply chain pressures and evolving distribution channels demand that manufacturers and purchasers adopt more sophisticated sourcing, pricing, and evidence-generation strategies. Companies that successfully align product development with care delivery trends, secure diversified and resilient supply chains, and demonstrate value through clinical and real-world evidence will be best positioned to lead in this evolving category. The path forward hinges on a pragmatic blend of design excellence, operational robustness, and close collaboration with providers to ensure devices meet the needs of clinicians, caregivers, and patients alike.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Percutaneous Endoscopic Gastrostomy Device Market, by Device Type

  • 8.1. Balloon Retention Devices
  • 8.2. Non-Balloon Retention Devices

9. Percutaneous Endoscopic Gastrostomy Device Market, by End User

  • 9.1. Ambulatory Surgery Centers
  • 9.2. Home Healthcare Settings
  • 9.3. Hospitals

10. Percutaneous Endoscopic Gastrostomy Device Market, by Distribution Channel

  • 10.1. Online
  • 10.2. Offline

11. Percutaneous Endoscopic Gastrostomy Device Market, by Material

  • 11.1. Polyurethane Devices
  • 11.2. Silicone Devices

12. Percutaneous Endoscopic Gastrostomy Device Market, by Procedure

  • 12.1. Initial Placement
  • 12.2. Replacement Procedures

13. Percutaneous Endoscopic Gastrostomy Device Market, by Age Group

  • 13.1. Adult Patients
  • 13.2. Pediatric Patients

14. Percutaneous Endoscopic Gastrostomy Device Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Percutaneous Endoscopic Gastrostomy Device Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Percutaneous Endoscopic Gastrostomy Device Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Percutaneous Endoscopic Gastrostomy Device Market

18. China Percutaneous Endoscopic Gastrostomy Device Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Applied Medical Technology
  • 19.6. Avanos Medical
  • 19.7. Boston Scientific
  • 19.8. Cardinal Health
  • 19.9. ConMed
  • 19.10. Cook Group
  • 19.11. Danone
  • 19.12. Fresenius Kabi
  • 19.13. GBUK Group
  • 19.14. Nestle

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY BALLOON RETENTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY BALLOON RETENTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY BALLOON RETENTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY NON-BALLOON RETENTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY NON-BALLOON RETENTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY NON-BALLOON RETENTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY HOME HEALTHCARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY POLYURETHANE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY POLYURETHANE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY POLYURETHANE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY SILICONE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY SILICONE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY SILICONE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY INITIAL PLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY INITIAL PLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY INITIAL PLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY REPLACEMENT PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY REPLACEMENT PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY REPLACEMENT PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY ADULT PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY ADULT PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY ADULT PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PEDIATRIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PEDIATRIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PEDIATRIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 52. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 53. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 54. AMERICAS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 59. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 60. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 61. NORTH AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 64. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 65. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 66. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 67. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 68. LATIN AMERICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 88. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 89. MIDDLE EAST PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 93. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 95. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 96. AFRICA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 109. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 110. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 111. ASEAN PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 117. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 118. GCC PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPEAN UNION PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 129. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 130. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 131. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 132. BRICS PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 138. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 139. G7 PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 145. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 146. NATO PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 153. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 154. UNITED STATES PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 156. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 160. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY PROCEDURE, 2018-2032 (USD MILLION)
  • TABLE 161. CHINA PERCUTANEOUS ENDOSCOPIC GASTROSTOMY DEVICE MARKET SIZE, BY AGE GROUP, 2018-2032 (USD MILLION)